Theravance Biopharma (TBPH) Will Present VIBATIV Data at Upcoming Conference; Includes TOUR Study Numbers
Tweet Send to a Friend
Theravance Biopharma, Inc. (Nasdaq: TBPH) announced that data from new studies of VIBATIV (telavancin) will be presented at IDWeek⢠2016 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
